Atlas Trials

Lidocaine Versus Bupivacaine for Sphenopalatine Ganglion Block

Clinical trial NCT05269147 · COMPLETED

Trial details

NCT number
NCT05269147
Sponsor
Huda Fahmy Mahmoud, PhD
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Septum; Deviation, Congenital
Start date
2022-03-01
Primary completion
2022-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.